Development and progression of cancer cachexia: Perspectives from bench to bedside
Cancer cachexia (CC) is a devastating syndrome characterized by weight loss, reduced fat mass and muscle mass that affects approximately 80% of cancer patients and is responsible for 22%–30% of cancer-associated deaths. Understanding underlying mechanisms for the development of CC are crucial to adv...
Main Authors: | Seongkyun Lim, Jacob L. Brown, Tyrone A. Washington, Nicholas P. Greene |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2020-12-01
|
Series: | Sports Medicine and Health Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666337620300664 |
Similar Items
-
Obesity worsens mitochondrial quality control and does not protect against skeletal muscle wasting in murine cancer cachexia
by: Thomas D. Cardaci, et al.
Published: (2024-02-01) -
Comparative plasma proteomics in muscle atrophy during cancer‐cachexia and disuse: The search for atrokines
by: Seongkyun Lim, et al.
Published: (2020-10-01) -
Mitochondrial Function and Protein Turnover in the Diaphragm are Altered in LLC Tumor Model of Cancer Cachexia
by: Megan E. Rosa-Caldwell, et al.
Published: (2020-10-01) -
C/EBPβ promotes the expression of atrophy‐inducing factors by tumours and is a central regulator of cancer cachexia
by: Hamood AlSudais, et al.
Published: (2022-02-01) -
The time-course of cancer cachexia onset reveals biphasic transcriptional disruptions in female skeletal muscle distinct from males
by: Francielly Morena da Silva, et al.
Published: (2023-07-01)